The current study was conducted to investigate the metabolic effects of EMPA in hearts with cardiac dysfunction post-MI.<h4>Methods</h4>Bioinformatics analysis revealed activation of the NF-κB/NLRP3/pyroptosis signaling pathway in AMI patients. Here, NFKB1 is linked to myocardial infarction.